Drug Discovery World

MARCH 13, 2024

According to Statista, revenue in this sector is expected to grow at an annual rate of 6.77%, resulting in a market volume of US$2,208m by 2028 1. Another successful NUS spin-out is RNA company Ephyra, now based in Cambridge, England, which is developing a new class of therapeutics known as designer sponge RNAs.

Government 173

Government Science Pharmaceuticals Vaccine 173

Drug Discovery World

SEPTEMBER 28, 2022

In fact, the market research firm, Bekryl, predicts that AI has the potential to offer over $70 billion in savings for the drug discovery process by 2028. . The significance of these predictions has not been lost on investors in the health and technology space. billion in 2021, an increase of 79% from 2020.

Pharma Companies 130

Pharma Companies Hospitals Clinical Trials Drugs 130

Drug Discovery World

AUGUST 8, 2023

India will make its mark as a growing market, potential competitor or partner in manufacturing and R&D, and as a location for clinical trials.” The country, many predict, will be the most populous in the world by 2050. 7 While external investment is essential, so is governmental support and investment.

Research 130

Research Pharmacy Pharmaceuticals Government 130

Drug Discovery World

AUGUST 10, 2022

And now, with more than 600 CAR T trials recruiting or ongoing, these cells represent a majority of the cellular immunotherapies in development today. Unlike qPCR, which requires users to generate a standard curve to estimate the concentration of DNA or RNA in a sample, ddPCR technology quantifies nucleic acids directly. 2021) 14:7.

Therapies 246

Therapies Virus Treatment Engineering 246